Simpson Thacher & Bartlett represented the initial purchaser and the co-manager in the offering. Weibo Corporation (“Weibo”) (NASDAQ: WB) (HKSE: 9898) announced its US$330 million Convertible Senior...
Weibo Corporation’s $330 Million Convertible Notes Offering
Hesai Technology’s Initial Public Offering
Fangda Partners advised the underwriters on the deal. Hesai Technology executed a $190 million IPO on NASDAQ, marking the largest Chinese IPO listed in the US capital...
Hesai Group’s Initial Public Offering
Skadden, Maples and Calder and Commerce & Finance Law Offices advised Hesai, while Fangda and Latham & Watkins advised the underwriters involved. Hesai Group was successfully...
Bilibili’s Equity Offering and Notes Exchange
Skadden advised Bilibili Inc. and Davis Polk advised the underwriter involved. Bilibili announced an equity underwriting and notes exchange agreement with Goldman Sachs (Asia) L.L.C. to issue...
Giant Biogene Holding Co., Ltd’s Listing on the Hong Kong Stock Exchange
Freshfields Bruckhaus Deringer advised Goldman Sachs (Asia) L.L.C. and China International Capital Corporation Hong Kong Securities Limited, the joint sponsors and the underwriters. Maples and Calder,...
Tencent Music Entertainment Group’s Secondary Listing on The HKSE
Slaughter and May, Maples and Calder, Davis Polk & Wardwell and Han Kun Law Offices advised Tencent Holdings Limited on the deal. Freshfields Bruckhaus Deringer and...
Li Auto’s $2 Billion At-The-Market Offering
Davis Polk, working alongside King & Wood Mallesons advised the sales agents in the offering. Li Auto Inc. announced its at-the-market offering program, under which Li Auto may...
KE Holdings Inc. (Beike)’s Dual Primary Listing in Hong Kong
Harneys acted as Cayman Islands to Beike, Freshfields Bruckhaus Deringer as to Hong Kong law, Skadden, Arps, Slate, Meagher & Flom LLP as to US law...
Asymchem’s $917 Million Hong Kong Listing
Latham & Watkins LLP advised the underwriters in the transaction while Cooley and JunHe represented Asymchem Laboratories. Asymchem Laboratories (Tianjin) Co., Ltd (Asymchem), a leading drug...
Clover Biopharmaceuticals’ US$257.8 Million Hong Kong Initial Public Offering
Skadden advised Goldman Sachs (Asia) L.L.C., China International Capital Corporation Hong Kong Securities Limited and Credit Suisse (Hong Kong) Limited as lead underwriters on the IPO....
Kakaopay’s US$1.3 Billion IPO
Paul Hastings advised Goldman Sachs, J.P. Morgan and Samsung Securities on the deal. Bae, Kim & Lee LLC advised the underwriters on the deal. Goldman Sachs,...
Nio’s $2 Billion At-The Market Shares Offering
Latham & Watkins advised the sales agents in the transaction. Nio Inc (Nio), a leading company in the premium smart electric vehicle market in China, has...